|
HOMEZ expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.51439999932046E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.585000E-04 |
| Normal-vs-Stage2 |
1.36059999999993E-06 |
| Normal-vs-Stage3 |
8.44750000000838E-05 |
| Normal-vs-Stage4 |
1.66332000000047E-05 |
| Stage1-vs-Stage2 |
2.531600E-01 |
| Stage1-vs-Stage3 |
4.074400E-01 |
| Stage1-vs-Stage4 |
1.766950E-01 |
| Stage2-vs-Stage3 |
8.218000E-01 |
| Stage2-vs-Stage4 |
6.033200E-01 |
| Stage3-vs-Stage4 |
5.372000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.3913000024578E-08 |
| Normal-vs-AfricanAmerican |
4.278600E-03 |
| Normal-vs-Asian |
4.848300E-02 |
| Caucasian-vs-AfricanAmerican |
3.913400E-01 |
| Caucasian-vs-Asian |
6.019600E-01 |
| AfricanAmerican-vs-Asian |
8.543000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.04590019872819E-10 |
| Normal-vs-Female |
7.312400E-02 |
| Male-vs-Female |
1.178650E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.878310E-03 |
| Normal-vs-Extreme_Weight |
1.84952053672305E-12 |
| Normal-vs-Obese |
7.11240000228486E-08 |
| Normal-vs-Extreme_Obese |
7.998000E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.480400E-02 |
| Normal_Weight-vs-Obese |
6.299400E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.215800E-01 |
| Extreme_Weight-vs-Obese |
3.064100E-02 |
| Extreme_Weight-vs-Extreme_Obese |
2.721000E-01 |
| Obese-vs-Extreme_Obese |
4.326000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.153800E-04 |
| Normal-vs-Age(41-60Yrs) |
5.08209999638964E-08 |
| Normal-vs-Age(61-80Yrs) |
3.67500000000298E-05 |
| Normal-vs-Age(81-100Yrs) |
1.50809999999169E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.964200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.756200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.542000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.584400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.442400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.074600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.46949160909571E-12 |
| Normal-VS-Type2 PRCC |
1.380900E-04 |
| Normal-VS-KIRP CIMP |
6.30900000020418E-08 |
| Normal-VS-Unclassified PRCC |
3.80079999999783E-05 |
| Type1 PRCC-VS-Type2 PRCC |
1.706230E-01 |
| Type1 PRCC-VS-KIRP CIMP |
7.368100E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
6.605000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.619890E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
5.532600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.466610E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.25290003003687E-09 |
| Normal-vs-N1 |
4.393700E-04 |
| Normal-vs-N2 |
3.95279997622566E-09 |
| N0-vs-N1 |
2.646600E-01 |
| N0-vs-N2 |
3.48670000005491E-06 |
| N1-vs-N2 |
2.144600E-03 |
|
|
